Condition
Bronchoalveolar Lavage Fluid
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Recruiting1
Terminated1
Unknown1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06815666Phase 2Recruiting
BAL Fluid Biomarkers in Sarcoma
NCT06333379CompletedPrimary
Aspergillosis Detection Via EBC-GM in Ventilated Patients
NCT04051372UnknownPrimary
Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL
NCT00146497Phase 4Terminated
Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants
Showing all 4 trials